Press Release: Clinical Study in UK to Evaluate ReGenerCell(TM) for Diabetic Foot Ulcer Treatment Tuesday, May 31st, 2016 Quote: NORTHRIDGE, CA and PERTH, AUSTRALIA and CAMBRIDGE, UNITED KINGDOM — (Marketwired) — May 30, 2016 — Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY) Study will evaluate preliminary safety and effectiveness in a cohort of up to 24 patients Innovative regenerative technology will use patients’ own skin cells to try to close chronic Diabetic Foot Ulcer (DFUs) DFUs represent a significant new potential patient population for Avita Medical The first patient suffering from a Diabetic Foot Ulcer (DFU) has been enrolled in a clinical trial in the UK aimed at evaluating the feasibility of the medical device ReGenerCell in the safe and effective treatment of this widespread complication of diabetes, Avita Medical said today
See more here:
ReGenerCell for diabetic foot ulcers
Leave a Reply